-
1
-
-
14944385553
-
Global cancer statistics, 2002
-
Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
-
(2005)
CA Cancer J Clin
, vol.55
, pp. 74-108
-
-
Parkin, D.M.1
Bray, F.2
Ferlay, J.3
Pisani, P.4
-
2
-
-
67649449102
-
Gastric cancer
-
Catalano V, Labianca R, Beretta GD, Gatta G, de Braud F, Van Cutsem E. Gastric cancer. Crit Rev Oncol Hematol 2009;71:127-64.
-
(2009)
Crit Rev Oncol Hematol
, vol.71
, pp. 127-164
-
-
Catalano, V.1
Labianca, R.2
Beretta, G.D.3
Gatta, G.4
de Braud, F.5
van Cutsem, E.6
-
3
-
-
0033853456
-
Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries
-
Botterweck AA, Schouten LJ, Volovics A, Dorant E, van Den Brandt PA. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol 2000;29:645-54.
-
(2000)
Int J Epidemiol
, vol.29
, pp. 645-654
-
-
Botterweck, A.A.1
Schouten, L.J.2
Volovics, A.3
Dorant, E.4
van Den Brandt, P.A.5
-
4
-
-
33847638137
-
Estimates of the cancer incidence and mortality in Europe in 2006
-
Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007;18:581-92.
-
(2007)
Ann Oncol
, vol.18
, pp. 581-592
-
-
Ferlay, J.1
Autier, P.2
Boniol, M.3
Heanue, M.4
Colombet, M.5
Boyle, P.6
-
5
-
-
0031784518
-
Classifcation of adenocarcinoma of the oesophagogastric junction
-
Siewert JR, Stein HJ. Classifcation of adenocarcinoma of the oesophagogastric junction. Br J Surg 1998; 85: 1457-9.
-
(1998)
Br J Surg
, vol.85
, pp. 1457-1459
-
-
Siewert, J.R.1
Stein, H.J.2
-
6
-
-
33846145078
-
Adenocarcinoma of the esophago-gastric junction
-
Siewert JR, Stein HJ, Feith M. Adenocarcinoma of the esophago-gastric junction. Scand J Surgery 2006;95:260-9.
-
(2006)
Scand J Surgery
, vol.95
, pp. 260-269
-
-
Siewert, J.R.1
Stein, H.J.2
Feith, M.3
-
7
-
-
43449107054
-
Differences in the pattern of presentation and treatment of proximal and distal gastric cancer: Results of the 2001 gastric patient care evaluation
-
Wilkinson NW, Howe J, Gay G, Patel Parekh L, Scott Conner C, Donohue J. Differences in the pattern of presentation and treatment of proximal and distal gastric cancer: results of the 2001 gastric patient care evaluation. Ann Surg Oncol 2008;15:1644-50.
-
(2008)
Ann Surg Oncol
, vol.15
, pp. 1644-1650
-
-
Wilkinson, N.W.1
Howe, J.2
Gay, G.3
Patel Parekh, L.4
Scott Conner, C.5
Donohue, J.6
-
8
-
-
33845410539
-
Emerging aspects of oesophageal and gastro-oesophageal junction cancer histopathology-an update for the surgical oncologist
-
Griffths EA, Pritchard SA, Mapstone NP, Welch IM. Emerging aspects of oesophageal and gastro-oesophageal junction cancer histopathology-an update for the surgical oncologist. World J Surg Oncol 2006;4:82.
-
(2006)
World J Surg Oncol
, vol.4
, pp. 82
-
-
Griffths, E.A.1
Pritchard, S.A.2
Mapstone, N.P.3
Welch, I.M.4
-
9
-
-
0035142280
-
The pattern of metastatic lymph node dissemination from adenocarcinoma of the esophagogastric junction
-
Dresner SM, Lamb PJ, Bennet MK, Hayes N, Griffn SM. The pattern of metastatic lymph node dissemination from adenocarcinoma of the esophagogastric junction. Surgery 2001;129:103-9.
-
(2001)
Surgery
, vol.129
, pp. 103-109
-
-
Dresner, S.M.1
Lamb, P.J.2
Bennet, M.K.3
Hayes, N.4
Griffn, S.M.5
-
10
-
-
0037156943
-
The pattern of recurrence of adenocarcinoma of the oesophago-gastric junction
-
Wajman J, Bennett MK, Raimes SA, Griffn SM. The pattern of recurrence of adenocarcinoma of the oesophago-gastric junction. Br J Cancer 2002; 86:1223-9.
-
(2002)
Br J Cancer
, vol.86
, pp. 1223-1229
-
-
Wajman, J.1
Bennett, M.K.2
Raimes, S.A.3
Griffn, S.M.4
-
11
-
-
80055102981
-
Neoadjuvant chemoradiotherapy for resectable oesophageal and gastro-oesophageal junction cancer. Do we need another randomized trial?
-
Hingorani M, Crosby T, Maraveyas A, Dixit S, Bateman A, Roy R. Neoadjuvant chemoradiotherapy for resectable oesophageal and gastro-oesophageal junction cancer. Do we need another randomized trial? Clin Oncol (R Coll Radiol) 2011;23:696-705.
-
(2011)
Clin Oncol (R Coll Radiol
, vol.23
, pp. 696-705
-
-
Hingorani, M.1
Crosby, T.2
Maraveyas, A.3
Dixit, S.4
Bateman, A.5
Roy, R.6
-
12
-
-
60849118127
-
Phase iii comparison of preoperative chemotherapy compared with chemoradio-therapy in patients with locally advanced adenocarcinoma of the esophagogastric junction
-
Stahl M, Walz MK, Stuschke M, et al. Phase iii comparison of preoperative chemotherapy compared with chemoradio-therapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol 2009;27:851-6.
-
(2009)
J Clin Oncol
, vol.27
, pp. 851-856
-
-
Stahl, M.1
Walz, M.K.2
Stuschke, M.3
-
13
-
-
77951084425
-
Adjuvant chemoradio-therapy in patients with stage iii or iv radically resected gastric cancer: A pilot study
-
Orditura M, De Vita F, Muto P, et al. Adjuvant chemoradio-therapy in patients with stage iii or iv radically resected gastric cancer: a pilot study. Arch Surg 2010;145:233-8.
-
(2010)
Arch Surg
, vol.145
, pp. 233-238
-
-
Orditura, M.1
de Vita, F.2
Muto, P.3
-
14
-
-
64249099411
-
-
New York, NY: Springer-Verlag
-
Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, eds. AJCC Cancer Staging Manual. 7 th ed. New York, NY: Springer-Verlag; 2009.
-
(2009)
AJCC Cancer Staging Manual. 7 Th Ed
-
-
Edge, S.B.1
Byrd, D.R.2
Compton, C.C.3
Fritz, A.G.4
Greene, F.L.5
Trotti, A.6
-
15
-
-
0003575141
-
-
United States, Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Cancer Therapy Evaluation Program (ctep, Bethesda, MD: ctep, cited May 12, 2011
-
United States, Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Cancer Therapy Evaluation Program (ctep). Common Toxicity Criteria (CTC). Ver. 2.0. Bethesda, MD: ctep; 1999. [Available online at http://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/ctcv20_4-30-992.pdf; cited May 12, 2011]
-
(1999)
Common Toxicity Criteria (CTC). Ver. 2.0
-
-
-
16
-
-
0028969271
-
Toxicity criteria of the Radiation Therapy Oncology Group (rtog) and the European Organiza-tion for Research and Treatment of Cancer (eortc)
-
Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (rtog) and the European Organiza-tion for Research and Treatment of Cancer (eortc). Int J Radiat Oncol Biol Phys 1995;31:1341-6.
-
(1995)
Int J Radiat Oncol Biol Phys
, vol.31
, pp. 1341-1346
-
-
Cox, J.D.1
Stetz, J.2
Pajak, T.F.3
-
17
-
-
79959373978
-
Japanese gastric cancer t reatment guidelines 2010 (ver. 3)
-
Japanese Gastric Cancer Association
-
Japanese Gastric Cancer Association. Japanese gastric cancer t reatment guidelines 2010 (ver. 3). Gastric Cancer 2011; 14: 113-23.
-
(2011)
Gastric Cancer
, vol.14
, pp. 113-123
-
-
-
18
-
-
84861875920
-
Transthoracic resection versus non-transthoracic resection for gastroesophageal junction cancer: A meta-analysis
-
Yang K, Chen HN, Chen XZ, et al. Transthoracic resection versus non-transthoracic resection for gastroesophageal junction cancer: a meta-analysis. PLoS One 2012;7:e37698.
-
(2012)
PLoS One
, vol.7
-
-
Yang, K.1
Chen, H.N.2
Chen, X.Z.3
-
19
-
-
0028305674
-
Pathologic assessment of tumor regression after preoperative chemora-diotherapy of esophageal carcinoma
-
Mandard AM, Dalibard F, Mandard JC, et al. Pathologic assessment of tumor regression after preoperative chemora-diotherapy of esophageal carcinoma. Cancer 1994;73:2680-6.
-
(1994)
Cancer
, vol.73
, pp. 2680-2686
-
-
Mandard, A.M.1
Dalibard, F.2
Mandard, J.C.3
-
20
-
-
33845382806
-
Nonparametric estimation from incomplete observations
-
Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
-
(1958)
J Am Stat Assoc
, vol.53
, pp. 457-481
-
-
Kaplan, E.L.1
Meier, P.2
-
21
-
-
3042668007
-
Biostatistics 203. Survival analysis
-
Chan YH. Biostatistics 203. Survival analysis. Singapore Med J 2004;45: 249-56.
-
(2004)
Singapore Med J
, vol.45
, pp. 249-256
-
-
Chan, Y.H.1
-
22
-
-
0029737381
-
A comparison of multimodal therapy and surgery for adenocarcinoma
-
Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TP. A comparison of multimodal therapy and surgery for adenocarcinoma. N Engl J Med 1996;335:462-7.
-
(1996)
N Engl J Med
, vol.335
, pp. 462-467
-
-
Walsh, T.N.1
Noonan, N.2
Hollywood, D.3
Kelly, A.4
Keeling, N.5
Hennessy, T.P.6
-
23
-
-
41949119177
-
Phase iii trial of trimodality therapy with cisplatin, fuorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer. calgb 9781
-
Tepper J, Krasna MJ, Niedzwiecki D, et al. Phase iii trial of trimodality therapy with cisplatin, fuorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer. calgb 9781. J Clin Oncol 2008;26:1086-92.
-
(2008)
J Clin Oncol
, vol.26
, pp. 1086-1092
-
-
Tepper, J.1
Krasna, M.J.2
Niedzwiecki, D.3
-
24
-
-
0035863382
-
Randomized trial of preoperative chemo-radiation versus surgery alone in patients with locoregional esophageal carcinoma
-
Urba SG, Orringer MB, Turrisi A, Iannettoni M, Forastiere A, Strawderman M. Randomized trial of preoperative chemo-radiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 2001;19:305-13.
-
(2001)
J Clin Oncol
, vol.19
, pp. 305-313
-
-
Urba, S.G.1
Orringer, M.B.2
Turrisi, A.3
Iannettoni, M.4
Forastiere, A.5
Strawderman, M.6
-
25
-
-
24044509153
-
Su rger y alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: A randomised controlled phase iii trial
-
Burmeister BH, Smithers BM, Gebski V, et al. Su rger y alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase iii trial. Lancet Oncol 2005;6:659-68.
-
(2005)
Lancet Oncol
, vol.6
, pp. 659-668
-
-
Burmeister, B.H.1
Smithers, B.M.2
Gebski, V.3
-
26
-
-
3042584502
-
Preoperative chemora-diotherapy for oesophageal cancer: A systematic review and meta-analysis
-
Fiorica F, Di Bona D, Schepis F, et al. Preoperative chemora-diotherapy for oesophageal cancer: a systematic review and meta-analysis. Gut 2004;53:925-30.
-
(2004)
Gut
, vol.53
, pp. 925-930
-
-
Fiorica, F.1
Di Bona, D.2
Schepis, F.3
-
27
-
-
33747763374
-
Neoadjuvant chemoradiation may increase the risk of respiratory complications and sepsis after transthoracic esophagectomy
-
Reynolds JV, Ravi N, Hollywood D, et al. Neoadjuvant chemoradiation may increase the risk of respiratory complications and sepsis after transthoracic esophagectomy. J Thorac Cardiovasc Surg 2006;132:549-55.
-
(2006)
J Thorac Cardiovasc Surg
, vol.132
, pp. 549-555
-
-
Reynolds, J.V.1
Ravi, N.2
Hollywood, D.3
-
28
-
-
84861679981
-
Preopera-tive chemoradiotherapy for esophageal or junctional cancer
-
Van Hagen P, Hulshof MC, van Lanschot JJ, et al. Preopera-tive chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 2012;366:2074-84.
-
(2012)
N Engl J Med
, vol.366
, pp. 2074-2084
-
-
van Hagen, P.1
Hulshof, M.C.2
van Lanschot, J.J.3
-
29
-
-
84857557133
-
Phase ii trial of pre-operative chemoradiotherapy with oxaliplatin, cisplatin, and 5-fu in locally advanced esophageal and gastric cancer
-
Pera M, Gallego R, Montagut C, et al. Phase ii trial of pre-operative chemoradiotherapy with oxaliplatin, cisplatin, and 5-fu in locally advanced esophageal and gastric cancer. Ann Oncol 2012;23:664-70.
-
(2012)
Ann Oncol
, vol.23
, pp. 664-670
-
-
Pera, M.1
Gallego, R.2
Montagut, C.3
-
30
-
-
84872811742
-
Neoadjuvant concurrent chemoradiotherapy with capecitabine and oxali-platin in patients with locally advanced esophageal cancer
-
Wahba HA, El-Hadaad HA, Abd-Ellatif EA. Neoadjuvant concurrent chemoradiotherapy with capecitabine and oxali-platin in patients with locally advanced esophageal cancer. Med Oncol 2012;29:1693-8.
-
(2012)
Med Oncol
, vol.29
, pp. 1693-1698
-
-
Wahba, H.A.1
El-Hadaad, H.A.2
Abd-Ellatif, E.A.3
-
31
-
-
63949084961
-
Multi-center phase ii trial of chemo-radiotherapy with 5-fuorouracil, leu-covorin and oxaliplatin in locally advanced esophageal cancer
-
Chiarion-Sileni V, Innocente R, Cavina R, et al. Multi-center phase ii trial of chemo-radiotherapy with 5-fuorouracil, leu-covorin and oxaliplatin in locally advanced esophageal cancer. Cancer Chemother Pharmacol 2009; 63: 1111-19.
-
(2009)
Cancer Chemother Pharmacol
, vol.63
, pp. 1111-1119
-
-
Chiarion-Sileni, V.1
Innocente, R.2
Cavina, R.3
-
32
-
-
79551583770
-
A multicenter phase ii study of induction chemotherapy with folfox-4 and cetuximab followed by radiation and cetuximab in locally advanced oesophageal cancer
-
De Vita F, Orditura M, Martinelli E, et al. A multicenter phase ii study of induction chemotherapy with folfox-4 and cetuximab followed by radiation and cetuximab in locally advanced oesophageal cancer. Br J Cancer 2011;10 4:427-32.
-
(2011)
Br J Cancer
, vol.10
, Issue.4
, pp. 427-432
-
-
de Vita, F.1
Orditura, M.2
Martinelli, E.3
-
33
-
-
71649083039
-
Phase ii trial of preop-erative irinotecan-cisplatin followed by concurrent irinote-can-cisplatin and radiotherapy for resectable locally advanced gastric and esophagogastric junction adenocarcinoma
-
Rivera F, Galan M, Tabernero J, et al. Phase ii trial of preop-erative irinotecan-cisplatin followed by concurrent irinote-can-cisplatin and radiotherapy for resectable locally advanced gastric and esophagogastric junction adenocarcinoma. Int J Radiat Oncol Biol Phys 2009: 75:1430-6.
-
(2009)
Int J Radiat Oncol Biol Phys
, vol.75
, pp. 1430-1436
-
-
Rivera, F.1
Galan, M.2
Tabernero, J.3
-
34
-
-
33748462703
-
Phase ii trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (rtog 9904): Quality of combined modality therapy and pathological response
-
Ajani JA, Winter K, Okawara GS, et al. Phase ii trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (rtog 9904): quality of combined modality therapy and pathological response. J Clin Oncol 2006;24:3953-8.
-
(2006)
J Clin Oncol
, vol.24
, pp. 3953-3958
-
-
Ajani, J.A.1
Winter, K.2
Okawara, G.S.3
-
35
-
-
77956636233
-
Weekly chemotherapy with cisplatin and paclitaxel and concurrent radiation therapy as preoperative treatment in locally advanced esopha-geal cancer: A phase ii study
-
Orditura M, Galizia G, Napolitano V, et al. Weekly chemotherapy with cisplatin and paclitaxel and concurrent radiation therapy as preoperative treatment in locally advanced esopha-geal cancer: a phase ii study. Cancer Invest 2010; 28:820-7.
-
(2010)
Cancer Invest
, vol.28
, pp. 820-827
-
-
Orditura, M.1
Galizia, G.2
Napolitano, V.3
-
36
-
-
79955576900
-
Perioperative chemotherapy compared with surgery alone for resectable gastro-esophageal adenocarcinoma: An fnclcc and ffcd multicenter phase iii trial
-
Ychou M, Boige V, Pignon JP, et al. Perioperative chemotherapy compared with surgery alone for resectable gastro-esophageal adenocarcinoma: an fnclcc and ffcd multicenter phase iii trial. J Clin Oncol 2011; 29: 1715-21.
-
(2011)
J Clin Oncol
, vol.29
, pp. 1715-1721
-
-
Ychou, M.1
Boige, V.2
Pignon, J.P.3
|